Form D · Biotechnology
EdenRoc Sciences LLC
Worcester, MA · CIK 0001685567
Offering snapshot reported Nov 15, 2024 · SEC filing
- Reported sold
- $2.75M Offering amount: $50M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 7, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 15, 2024 | Initial | $2,750,000 | No comparison | 3 | SEC filing |
| Jul 16, 2024 | Amendment | $64,175,000 | $8,650,000vs Dec 26, 2023 | 50 | SEC filing |
| Dec 26, 2023 | Initial | $55,525,000 | No comparison | 41 | SEC filing |
| May 24, 2022 | Amendment | $35,900,016 | $16,800,000vs Nov 3, 2021 | 22 | SEC filing |
| Jan 19, 2022 | Amendment | $27,600,016 | $8,500,000vs Nov 3, 2021 | 19 | SEC filing |
| Nov 3, 2021 | Initial | $18,000,000 | No comparison | 10 | SEC filing |
| Nov 3, 2021 | Initial | $19,100,016 | No comparison | 15 | SEC filing |
| Jul 31, 2020 | Initial | $17,600,000 | No comparison | 11 | SEC filing |
| Jul 30, 2019 | Initial | $8,000,000 | No comparison | 4 | SEC filing |
| Feb 20, 2019 | Initial | $13,500,000 | No comparison | 4 | SEC filing |
| Mar 19, 2018 | Initial | $15,000,000 | No comparison | 2 | SEC filing |
| Jul 26, 2017 | Initial | $15,000,000 | No comparison | 3 | SEC filing |
| Sep 29, 2016 | Initial | $30,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-529496
Source: Form D, filed Nov 15, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jason Anderson | Director |
| Carlos Bustamante | Director |
| J. Taylor Crandall | Director |
| J.Taylor Crandall | Director |
| Todd Dickinson | Director |
| Mathew Easterday | Executive |
| Ed Green | Director |
| Gregory Lucier | Director |
| Christopher Mc Doniel | Executive |
| Edward Schulak | Director, Executive |
| David Sinclair | Director |
| Christopher Wibbleman | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 Barber Avenue
Worcester, MA, 01606
Worcester, MA, 01606